These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2858533

  • 1. Effect of implanted ethylene-vinyl alcohol copolymer matrices containing 5-fluorouracil on Ehrlich ascites carcinoma.
    Miyazaki S, Takeuchi S, Sugiyama M, Takada M, Hosokawa M, Koga Y, Kobayashi H.
    J Pharm Pharmacol; 1985 Jan; 37(1):64-6. PubMed ID: 2858533
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect of ethylene-vinyl acetate copolymer matrices containing 5-fluorouracil on Ehrlich ascites carcinoma in mice.
    Miyazaki S, Ishii K, Sugibayashi K, Morimoto Y, Takada M.
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3770-5. PubMed ID: 7160019
    [No Abstract] [Full Text] [Related]

  • 3. Antitumor effect of implanted ethylene-vinyl alcohol copolymer matrices containing anticancer agents on Ehrlich ascites carcinoma and P388 leukemia in mice.
    Miyazaki S, Takeuchi S, Hou WM, Hashiguchi N, Yokouchi C, Takada M, Hosokawa M, Koga Y, Kobayashi H.
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2490-8. PubMed ID: 4064208
    [No Abstract] [Full Text] [Related]

  • 4. Enhancement of antitumor activity of 5-fluorouracil by ribothymidine.
    Tezuka M, Chiba Y, Okada S, Tamemasa O.
    J Pharmacobiodyn; 1986 Aug; 9(8):683-7. PubMed ID: 3783412
    [Abstract] [Full Text] [Related]

  • 5. Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
    Ambaye RY, Indap MA.
    Cancer Lett; 1991 Apr; 57(1):21-6. PubMed ID: 1902758
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effect of 5-fluorouracil in combination with some additives which stimulate the formation of antineoplastic 5-fluorouracil nucleotides.
    Tamemasa O, Tezuka M.
    Gan; 1983 Apr; 74(2):285-90. PubMed ID: 6407888
    [Abstract] [Full Text] [Related]

  • 7. Transdermal delivery of 5-fluorouracil for induced ehrlich ascites carcinoma tumor in BALB/c mice and pharmacokinetic study.
    Chandrashekar NS, Hiremath SR.
    Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):235-9. PubMed ID: 18221066
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE, Young RC, Chabner BA.
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [Abstract] [Full Text] [Related]

  • 10. Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice.
    Haggag YA, Osman MA, El-Gizawy SA, Goda AE, Shamloula MM, Faheem AM, McCarron PA.
    Biomed Pharmacother; 2018 Sep; 105():215-224. PubMed ID: 29857301
    [Abstract] [Full Text] [Related]

  • 11. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK, Agarwal A, Rai G, Mishra P, Jain S, Mishra AK, Agrawal H, Agrawal GP.
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of 5-fluorouracil in combination with methoxyphenyl maleamic acid in murine tumors.
    Indap MA, Ambaye RY.
    J Postgrad Med; 1991 Oct; 37(4):211-5. PubMed ID: 1841970
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of antitumor effects of 5-fluorouracil combined with ultrasound on Ehrlich ascites tumor in vivo.
    Mohamed MM, Mohamed MA, Fikry NM.
    Ultrasound Med Biol; 2003 Nov; 29(11):1635-43. PubMed ID: 14654158
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of potentiation of antitumor activity of 5-fluorouracil by ribothymidine in a mouse tumor system.
    Tezuka M, Chiba Y, Tamemasa O, Okada S.
    J Pharmacobiodyn; 1986 Dec; 9(12):962-9. PubMed ID: 3572717
    [Abstract] [Full Text] [Related]

  • 15. Antitumour activity of 1-naphthol against L1210 leukaemia in vivo and Ehrlich ascites tumour cells in vivo and in vitro.
    Jones M, d'Arcy Doherty M, Cohen GM.
    Cancer Lett; 1986 Dec; 33(3):347-54. PubMed ID: 3802063
    [Abstract] [Full Text] [Related]

  • 16. Controlled release of 5-fluorouracil from hydrophilic ethylene-vinyl alcohol copolymer matrices.
    Miyazaki S, Takeuchi S, Sakamoto M, Takada M.
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3707-13. PubMed ID: 6671231
    [No Abstract] [Full Text] [Related]

  • 17. Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms.
    Gaballah HH, Gaber RA, Mohamed DA.
    Toxicol Appl Pharmacol; 2017 Feb 01; 316():27-35. PubMed ID: 28025107
    [Abstract] [Full Text] [Related]

  • 18. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H, Masuda H, Maehara Y, Sugimachi K, Inokuchi K.
    Cancer Treat Rep; 1986 Jul 01; 70(7):851-7. PubMed ID: 3719577
    [Abstract] [Full Text] [Related]

  • 19. Effect of liposome-entrapped 5-fluorouracil on Ehrlich ascites tumour bearing mice.
    Mazumder A.
    Indian J Biochem Biophys; 1981 Apr 01; 18(2):120-3. PubMed ID: 7309080
    [No Abstract] [Full Text] [Related]

  • 20. Antitumour effect of fibrinogen microspheres containing doxorubicin on Ehrlich ascites carcinoma.
    Miyazaki S, Hashiguchi N, Yokouchi C, Takada M, Hou WM.
    J Pharm Pharmacol; 1986 Aug 01; 38(8):618-20. PubMed ID: 2876081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.